DeepScribe
Specialty depth ambient scribe, built for complex specialty medicine rather than general primary care, with oncology as its center of gravity: the company reports 5 million oncology visits captured a year and roughly 40 percent of US cancer care visits documented on the platform, alongside tuned models for cardiology, urology, gastroenterology, orthopedics, neurology, and nephrology. Holds a 98.8 KLAS Emerging Company Spotlight score with A+ marks across all six measured categories, the highest independent rating in the category, plus 2025 KLAS Top 5 rankings for improving outcomes, patient experience, and clinician experience. Positioned as an Ambient Operating System rather than a scribe: bidirectional integration with Epic, athenahealth, NextGen, and eClinicalWorks reads chart context before the visit and writes structured data into discrete fields after, pulling prior notes, labs, imaging, medications, and diagnoses forward into the current note. AI coding builds HCC, CPT, and ICD-10 suggestions into the note, SmartPrep adds pre visit intelligence for oncology, and Customization Studio learns each clinician's documentation style. Conversations supported in more than 110 languages. Founded 2017.
Capability Axes
Ambient capture and specialty tuned note generation is the product, extended by AI coding and pre visit intelligence. All model driven.
The strongest independent rating in the ambient documentation category: a 98.8 KLAS Emerging Company Spotlight score with A+ marks across all six measured categories, plus 2025 KLAS Top 5 rankings across outcomes, patient experience, and clinician experience. KLAS is buyer survey based rather than vendor asserted. Supported by an August 2025 study in Journal of Clinical Pathways reporting improvements in diagnosis capture and note quality in oncology, which is specialty specific evidence rather than a general claim.
Genuinely bidirectional rather than one way push: reads problems, medications, labs, and prior notes before the encounter and writes structured data back into discrete EHR fields after, syncing against the EHR schedule, across Epic, athenahealth, NextGen, and eClinicalWorks. Reading the chart before the visit is what enables the longitudinal note, and it is a materially deeper integration than transcript only scribes.
No public pricing, no self serve signup, and no trial; all purchases run through enterprise sales. Third party estimates of roughly $350 to $500 per provider per month, with some reports near $750, are recorded in the pricing record and labeled as estimates.
The clearest specialty positioning in the lane, stated as a deliberate focus rather than breadth: oncology first with a reported 40 percent of US cancer care visits, plus tuned models for cardiology, urology, gastroenterology, orthopedics, neurology, and nephrology, and more than 110 languages. The company is explicit that the fit is complex longitudinal specialty care rather than short low acuity visits.
Pricing
Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.
| Entry Price | Pricing Basis | BAA Tier | Implementation | Source |
|---|---|---|---|---|
|
Estimated $350 to $500 per provider per month
$350 baseline
|
Enterprise contracts priced per provider per month | — | — | Third Party Estimated |
ESTIMATED. No public pricing, no self serve signup, and no trial; all purchases run through enterprise sales. Third parties estimate roughly $350 to $500 per provider per month, with some reports near $750, varying by organization size and integration depth. Not confirmed by the vendor. The premium is positioned against complex longitudinal specialty care; for short low acuity visits, cheaper generalist scribes cover the same job.